Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective

[1]  E. Rosen,et al.  Mice with a Severe Deficiency of the Endothelial Protein C Receptor Gene Develop, Survive, and Reproduce Normally, and Do not Present with Enhanced Arterial Thrombosis after Challenge , 2002, Thrombosis and Haemostasis.

[2]  Yunjuan Sun,et al.  p38 Mitogen-activated Protein Kinase Mediates Hypoxic Regulation of Mdm2 and p53 in Neurons* , 2002, The Journal of Biological Chemistry.

[3]  Toshiyuki Obata,et al.  Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53* , 2002, The Journal of Biological Chemistry.

[4]  W. Ruf,et al.  Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.

[5]  M. Matsuzaki,et al.  Orphan G Protein-coupled Receptor, GPR41, Induces Apoptosis via a p53/Bax Pathway during Ischemic Hypoxia and Reoxygenation* , 2001, The Journal of Biological Chemistry.

[6]  A. Hoffmann,et al.  Hypoxia‐induced upregulation of eNOS gene expression is redox‐sensitive: A comparison between hypoxia and inhibitors of cell metabolism , 2001, Journal of cellular physiology.

[7]  T. Ogihara,et al.  Contribution of Bcl-2, but Not Bcl-xL and Bax, to Antiapoptotic Actions of Hepatocyte Growth Factor in Hypoxia-Conditioned Human Endothelial Cells , 2001, Hypertension.

[8]  L. Gelbert,et al.  Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis* , 2001, The Journal of Biological Chemistry.

[9]  Berislav V. Zlokovic,et al.  Anti-Inflammatory, Antithrombotic, and Neuroprotective Effects of Activated Protein C in a Murine Model of Focal Ischemic Stroke , 2001, Circulation.

[10]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[11]  Y. Lazebnik,et al.  Caspases Disrupt the Nuclear-Cytoplasmic Barrier , 2000, The Journal of cell biology.

[12]  T. Noguchi,et al.  Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. , 2000, Blood.

[13]  Antony M. Carr,et al.  Piecing Together the p53 Puzzle , 2000, Science.

[14]  K. Reymann,et al.  The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Zhao,et al.  Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro , 2000, Glia.

[16]  M. Oren.  Regulation of the p53 Tumor Suppressor Protein* , 1999, The Journal of Biological Chemistry.

[17]  A. Folsom,et al.  Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1999, Circulation.

[18]  C. Esmon,et al.  Endothelial Protein C Receptor , 1999, Thrombosis and Haemostasis.

[19]  K. Fukudome,et al.  The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries. , 1999, Biochemical and biophysical research communications.

[20]  C. F. Bennett,et al.  The Role of Antiapoptotic Bcl-2 Family Members in Endothelial Apoptosis Elucidated with Antisense Oligonucleotides* , 1999, The Journal of Biological Chemistry.

[21]  A. Karsan,et al.  Mechanisms of Hypoxia-induced Endothelial Cell Death , 1999, The Journal of Biological Chemistry.

[22]  B. Festoff,et al.  Thrombin Perturbs Neurite Outgrowth and Induces Apoptotic Cell Death in Enriched Chick Spinal Motoneuron Cultures through Caspase Activation , 1998, The Journal of Neuroscience.

[23]  B. Zlokovic,et al.  Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. , 1998, The Journal of clinical investigation.

[24]  D. Cunningham,et al.  Signaling Pathways Involved in Thrombin-induced Cell Protection* , 1998, The Journal of Biological Chemistry.

[25]  S. Lipton,et al.  Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice , 1998, Nature Medicine.

[26]  J. Griffin,et al.  Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala‐activated protein C mediated by factor Va , 1997, Protein science : a publication of the Protein Society.

[27]  J. Griffin.  The thrombin paradox , 1995, Nature.

[28]  C. Cotman,et al.  Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  D. Thorley-Lawson,et al.  A novel form of Epstein-Barr virus latency in normal B cells in vivo , 1995, Cell.

[30]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[31]  B. Lämmle,et al.  Immunoblotting studies of the molecular forms of protein C in plasma. , 1988, Thrombosis research.

[32]  木村 征靖.  Orphan G protein-coupled receptor,GPR41,induces apoptosis via a p53/Bax pathway during ischemic hypoxia and reoxygenation , 2001 .

[33]  M. Kastan,et al.  Role of p53 in apoptosis. , 1997, Advances in pharmacology.

[34]  J. Griffin.  Blood coagulation. The thrombin paradox. , 1995, Nature.